Erythromelalgia in patients with essential thrombocythemia and polycythemia vera.
a Mayo Medical School, Mayo Clinic College of Medicine , Rochester , MN , USA.
Jennifer L
JL
Hou
b Department of Dermatology , Mayo Clinic , Rochester , MN , USA.
Oluwakemi
O
Onajin
c Division of Hematology , Mayo Clinic , Rochester , MN , USA.
Naseema
N
Gangat
b Department of Dermatology , Mayo Clinic , Rochester , MN , USA.
Mark D P
MD
Davis
c Division of Hematology , Mayo Clinic , Rochester , MN , USA.
Alexandra P
AP
Wolanskyj
D015415:Biomarkers; D003131:Combined Modality Therapy; D004916:Erythromelalgia / Q000175:diagnosis* / Q000209:etiology* / Q000628:therapy; D005260:Female; D006801:Humans; D008297:Male; D009154:Mutation; D011087:Polycythemia Vera / Q000150:complications* / Q000175:diagnosis* / Q000628:therapy; D063189:Symptom Assessment; D013920:Thrombocythemia, Essential / Q000150:complications* / Q000175:diagnosis* / Q000628:therapy
D015415:Biomarkers